PARSIPPANY, N.J., Oct. 7 /PRNewswire/ — DSM Pharmaceutical
Products, the custom manufacturing organization of Royal DSM NV, is
pleased to announce that their submission for the European
Outsourcing Awards, organized by Via Media UK Ltd, entitled
“Achieving substantial carbon dioxide footprint reduction for the
scale up of a drug intermediate,” was an award recipient at the 6th
October ceremony held in Paris, France.
DSM applied their InnoSyn™ route scouting services to
launch a collaborative research program to identify a faster route
for a drug intermediate using (bio)catalytic processes with the
same level of reliability and quality, yet with a reduced carbon
footprint of over fifty percent. The new process resulted also in
shorter cycle times due to fewer steps in the process.
Andre de Vries, Ph.D., Competence Manager for Homogeneous
Catalysis at DSM, commented, “This project involved scientists
covering all relevant areas of organic process development,
including biocatalysis and homogeneous catalysis. From the 10 new
identified routes, all less than 5 steps, the route combining a
biocatalytic and a metal-catalyzed step showed to be most
sustainable. In this way, DSM as the contract manufacturer is
contributing to extending the life cycle of the customer’s product
using innovation to decrease the eco footprint.”
Dr. Kevin Robinson, Editorial Director, Pharma magazine
and judging coordinator, stated: “The European Outsourcing Awards
judging panel is selected to give an impartial, professional and
wide-ranging level of expertise and is assembled exclusively from
leading healthcare organisations and top business school
academics.” DSM was nominated under the categories of Most Improved
Process, Plant or Facility, which focuses on expertise and
innovation to meet customer requirements for time-to-market, and
Best Contract Manufacturing Project, which focuses on production
and commercial manufacturing innovation, cost-eff
‘/>”/>